Christopher Fox

21PUBLICATIONS
190CO-AUTHORS
Innate immunityMedical infection agents (incl. prions)Characterisation of biological macromoleculesMedical molecular engineering of nucleic acids and proteinsNon-genetically modified uses of biotechnology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Nov 24, 2025
The ID93 + GLA-3M-052-LS vaccine candidate elicits mucosal and systemic immunogenicity and protective efficacy against <i>Mycobacterium tuberculosis</i> challenge in BCG-primed Collaborative Cross inbred mice.

Emily A Voigt, Anas Alsharaydeh, Darshan N Kasal

|Aug 02, 2024
Immunogenicity and safety of an <i>Entamoeba histolytica</i> adjuvanted protein vaccine candidate (LecA+GLA-3M-052 liposomes) in rhesus macaques.

Mayuresh M Abhyankar, Feifan Xu, Deborah Chavez

|Jul 31, 2024
A comparative immunological assessment of multiple clinical-stage adjuvants for the R21 malaria vaccine in nonhuman primates.

Prabhu S Arunachalam, NaYoung Ha, S Moses Dennison

|Jul 03, 2024
From hit to vial: Precision discovery and development of an imidazopyrimidine TLR7/8 agonist adjuvant formulation.

Dheeraj Soni, Francesco Borriello, David A Scott

|Nov 11, 2023
Enhancing breadth and durability of humoral immune responses in non-human primates with an adjuvanted group 1 influenza hemagglutinin stem antigen.

Maarten Swart, Harmjan Kuipers, Fin Milder

|Mar 06, 2023
Safety and immunogenicity of a thermostable ID93 + GLA-SE tuberculosis vaccine candidate in healthy adults.

Zachary K Sagawa, Cristina Goman, Aude Frevol

Pageof 4

Frequent Collaborators

4 joint publications

David Montefiori

3 joint publications

Mark Tomai

3 joint publications

Xiaoying Shen

3 joint publications

Georgia D Tomaras